WuXi had a banner 2012; Synteract buys German CRO;

> WuXi PharmaTech ($WX) says it has hit the $500 million revenue mark for 2012. News

> CDMO Almac has partnered with TTP Labtech to create a robust, antibody-free, homogeneous assay platform for their clients. More

> Synteract has signed a deal to buy German CRO Harrison Clinical Research for an undisclosed amount of money. Article

> Mitsubishi Chemical Holdings is buying Qualicaps for $650 million, planning to fold the business into its API manufacturing and other healthcare operations. Story

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.